Form 8-K - Current report:
SEC Accession No. 0001493152-24-040392
Filing Date
2024-10-08
Accepted
2024-10-08 08:05:22
Documents
30
Period of Report
2024-10-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 42104
2 ex99-1.htm EX-99.1 13180
3 ex99-1_001.jpg GRAPHIC 188974
4 ex99-1_002.jpg GRAPHIC 703995
5 ex99-1_003.jpg GRAPHIC 390499
6 ex99-1_004.jpg GRAPHIC 289906
7 ex99-1_005.jpg GRAPHIC 440977
8 ex99-1_006.jpg GRAPHIC 51027
9 ex99-1_007.jpg GRAPHIC 285458
10 ex99-1_008.jpg GRAPHIC 268395
11 ex99-1_009.jpg GRAPHIC 269135
12 ex99-1_010.jpg GRAPHIC 39711
13 ex99-1_011.jpg GRAPHIC 205101
14 ex99-1_012.jpg GRAPHIC 378266
15 ex99-1_013.jpg GRAPHIC 445603
16 ex99-1_014.jpg GRAPHIC 66879
17 ex99-1_015.jpg GRAPHIC 195334
18 ex99-1_016.jpg GRAPHIC 180522
  Complete submission text file 0001493152-24-040392.txt   6298949

Data Files

Seq Description Document Type Size
19 XBRL SCHEMA FILE meds-20241004.xsd EX-101.SCH 3009
20 XBRL LABEL FILE meds-20241004_lab.xml EX-101.LAB 34916
21 XBRL PRESENTATION FILE meds-20241004_pre.xml EX-101.PRE 24591
32 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3965
Mailing Address 2420 BRUNELLO TRACE LUTZ FL 33558
Business Address 2420 BRUNELLO TRACE LUTZ FL 33558 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 241359222
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)